
Onlookers and shareholders who want to get their hands on the annual report from biotech firm Orphazyme, which has been besieged by bad news in recent times, will have to wait a little longer.
Orphazyme has changed the publishing date, pushing back the report by almost a month from the previously announced March 15 to April 7, according to a company press release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app